Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men

November 2019 in “ Current Geriatrics Reports ”

Eric Bortnick, Vannita Simma‐Chiang, Olamide Omidele, Steven A. Kaplan

finasteride dutasteride tamsulosin benign prostatic hyperplasia BPH tadalafil Propecia Avodart Flomax Cialis

TLDR Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

The document reviewed medical therapies for treating benign prostatic hyperplasia (BPH) in elderly men, highlighting special considerations for this demographic. It discussed various medications, including Tamsulosin, which was noted for potential increased risks of dementia in older males. The FORTA classification system evaluated medications like Fesoterodine, Finasteride, and Dutasteride as beneficial for BPH treatment. The document also referenced studies on the efficacy and safety of drugs like tadalafil and combination therapies, emphasizing the importance of tailored treatment approaches for older adults with BPH.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Association of Suicidality and Depression With 5α-Reductase Inhibitors

90 citations , March 2017 in “JAMA Internal Medicine”

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

research Appropriateness of Oral Drugs for Long-Term Treatment of Lower Urinary Tract Symptoms in Older Persons: Results of a Systematic Literature Review and International Consensus Validation Process (LUTS-FORTA 2014)

111 citations , June 2015 in “Age and Ageing”

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

1707 citations , December 2003 in “The New England Journal of Medicine”

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.